Endothelin(B) receptors are functionally important in mediating vasoconstriction in the systemic circulation in patients with left ventricular systolic dysfunction

Journal of the American College of Cardiology

Volumn 33, Issue 4, 1999, Pages 932-938

  Cowburn, Peter J ^a   Cleland, John G F ^c   McArthur, John D ^b   MacLean, Margaret R ^a   McMurray, John J V ^a   Dargie, Henry J ^a   Morton, James J ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b WESTERN INFIRMARY   (United Kingdom)

^c Academic Unit   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN A RECEPTOR AGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR AGONIST;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE FAILURE; HUMAN; MALE; MEAN ARTERIAL PRESSURE; PATIENT SELECTION; PRIORITY JOURNAL; SYSTEMIC VASCULAR RESISTANCE; THERMODILUTION; VASOCONSTRICTION;

AGED; CHRONIC DISEASE; ENDOTHELIN-1; ENDOTHELIN-3; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; RECEPTOR, ENDOTHELIN B; RECEPTORS, ENDOTHELIN; SYSTOLE; VASOCONSTRICTION; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 0033558707     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00663-9     Document Type: Article

References (32)

1. Yanagisawa M., Kurihara H., Kimura S., et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature. 332:1988;411-415.
2. Furchgott R.F., Vanhoute P.N. Endothelium-derived relaxing and contracting factors. FASEB J. 3:1989;2007-2018.
3. Inoue A., Yanagisawa M., Kimura S., et al. The human endothelin family three structurally and pharmacologically distinct isopeptides predicted by three separate genes . Proc Natl Acad Sci USA. 86:1989;2863-2867.
4. Arai H., Hori S., Arimori I., Ohkubo H., Nakanishi S. Cloning and expression of a cDNA encoding an endothelin receptor. Nature. 348:1990;730-732.
5. Sakurai T., Yanagisawa M., Takuwa Y., et al. Cloning of a cDNA encoding a non-isopeptide selective subtype of the endothelin receptor. Nature. 348:1990;732-735.
6. Williams D.L., Jones K.L., Colton C.D., Nutt R.F. Identification of high affinity endothelin-1 receptor sub-types in human tissues. Biochem Biophys Res Commun. 180:1991;475-480.
7. Seo B., Oemar B.S., Siebenmann R., Von Segesser L., Luscher T.F. Both ET(A) and ET(B) receptors mediate contraction to endothelin-1 in human blood vessels. Circulation. 89:1994;1203-1208.
8. Haynes W.G., Strachan F.E., Webb D.J. Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Circulation. 92:1995;357-363.
9. DeNucci G., Thomas R., D'Orleans-Juste P., et al. Pressor effects of circulating endothelin are limited by its removal from the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor. Proc Natl Acad Sci USA. 85:1988;9797-9800.
10. McMurray J.J., Ray S.G., Abdullah I., Dargie H.J., Morton J.J. Plasma endothelin in chronic heart failure. Circulation. 85:1992;1374-1379.
11. Cody R.J., Haas G.J., Binkley P.F., Capers Q., Kelley R. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation. 85:1992;504-509.
12. Wei C.M., Lerman A., Rodeheffer R.J., et al. Endothelin in human congestive heart failure. Circulation. 89:1994;1580-1586.
13. Pousset F., Isnard R., Lechat P., et al. Prognostic value of plasma endothelin-1 in patients with chronic heart failure. Eur Heart J. 18:1997;254-258.
14. Kaddoura S., Poole-Wilson P.A. Endothelin-1 in heart failure a new therapeutic target? Lancet. 348:1996;418-419.
15. Cannan C.R., Burnett J.C. Jr, Lerman A. Enhanced coronary vasoconstriction to endothelin-B-receptor activation in experimental congestive heart failure. Circulation. 93:1996;646-651.
16. Love M.P., Haynes W.G., Gray G.A., Webb D.J., McMurray J.J.V. Vasodilator effects of endothelin-converting enzyme inhibition and endothelin ET(A) receptor blockade in chronic heart failure patients treated with ACE inhibitors. Circulation. 94:1996;2131-2137.
17. Grossman W., McLaurin L.P. Clinical measurement of vascular resistance and assessment of vasodilator drugs. Grossman W., Cardiac Catheterisation and Angiography. 1980;116-123 Lea and Fabiger, Philadelphia.
18. Cowburn P.J., Cleland J.G.F., McArthur J.D., et al. Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunction. Cardiovasc Res. 39:1998;563-570.
19. Lippton H.L., Ohlstein E.H., Summer W.R., Hyman A.L. Analysis of responses to endothelins in the rabbit pulmonary and systemic vascular beds. J Appl Physiol. 70:1991;331-341.
20. McCulloch K.M., Docherty C.C., Morecroft I., MacLean M.R. Endothelin B receptor mediated contraction in human pulmonary resistance arteries. Br J Pharmacol. 119:1996;1125-1130.
21. Cowburn P.J., Hillier C., Cleland J.G.F., et al. Impaired vasoconstriction to endothelin-1 in small arteries from patients with congestive-heart-failure. Circulation. 94:1996;428.
22. Fukuroda T., Fujikawa T., Ozaki S., Ishikawa K., Yano M., Nishikibe M. Clearance of circulating endothelin-1 by ETB receptors in rats. Biochem Biophys Res Commun. 199:1994;1461-1465.
23. Dupuis J., Goresky C.A., Fournier A. Pulmonary clearance of circulating endothelin-1 in dogs in vivo exclusive role of ET(B) receptors . J Appl Physiol. 81:1996;1510-1515.
24. Willette R.N., Sauermelch C.F., Storer B., Guiney S., Ohlstein E.H. Plasma immunoreactive endothelin-1 effects of endothelin antagonists with diverse affinity profiles for ETA and ETB receptor subtypes . Eur Heart J. 12:1997;611.
25. Yokokawa K., Kohno M., Yasunari K., Murakawa K., Takeda T. Endothelin-3 regulates endothelin-1 production in cultured human endothelial cells. Hypertension. 18:1991;304-315.
26. Harrison V.J., Randriantsoa A., Schoeffter P. Heterogeneity of endothelin-sarafatoxin receptors mediating contraction of pig coronary artery. Br J Pharmacol. 105:1992;511-513.
27. McCulloch K.M., Docherty C., MacLean M.R. Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries effect of chronic hypoxia in the rat . Br J Pharmacol. 123:1998;1621-1630.
28. C) from Xenopus laevis dermal melanophores. J Biol Chem. 268:1993;19126-19133.
29. Lecoin L., Sakurai T., Ngo N.T., Abe Y., Yanagisawa M., LeDourin N.M. Cloning and characterisation of a novel endothelin receptor subtype in the avian class. Proc Natl Acad Sci USA. 95:1998;3024-3029.
30. Kiowski W., Sutsch G., Hunziker P., et al. Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet. 346:1995;732-736.
31. Wada A., Tsutamoto T., Fukai D., et al. Comparison of the effects of selective endothelin ETA and ETB receptor antagonists in congestive heart failure. J Am Coll Cardiol. 30:1997;1385-1392.
32. Love M.P., Ferro C.J., Haynes W.G., Webb D.J., McMurray J.J.V. Selective or nonselective endothelin receptor blockade in chronic heart failure? Circulation. 94:1996;I-74.